Recombinant Human FN3K, N-His

Description of Recombinant Human FN3K, N-His

Introduction

Recombinant Human FN3K (fructosamine-3-kinase) is a protein that plays an important role in regulating glucose metabolism in the body. It is a member of the FN3K family of enzymes and is encoded by the FN3K gene. This protein has been extensively studied for its structure, activity, and potential applications in various fields.

Structure of Recombinant Human FN3K

Recombinant Human FN3K is a 38 kDa protein that consists of 342 amino acids. It has a conserved domain known as the fructosamine-3-kinase domain, which is responsible for its enzymatic activity. This protein also has a C-terminal domain that is involved in its binding to other proteins and cellular structures.

Activity of Recombinant Human FN3K

The main function of Recombinant Human FN3K is to catalyze the phosphorylation of fructosamines, which are formed when glucose reacts with proteins in the body. This process is known as glycation and can lead to the formation of advanced glycation end products (AGEs) which have been linked to various diseases such as diabetes, Alzheimer’s, and cancer.

Recombinant Human FN3K helps to prevent the accumulation of fructosamines by converting them into less reactive compounds, thus reducing the formation of AGEs. This activity is crucial in maintaining proper glucose metabolism and preventing the harmful effects of glycation.

Application of Recombinant Human FN3K

Recombinant Human FN3K has potential applications in various fields, including medicine, biotechnology, and food industry.

In medicine, this protein can be used as a therapeutic agent for the treatment of diseases associated with glycation, such as diabetes and Alzheimer’s. It has been shown to reduce the levels of AGEs in the body, which can help in managing the symptoms of these diseases.

In biotechnology, Recombinant Human FN3K can be used to produce recombinant proteins with reduced glycation, thus improving their stability and functionality. This is particularly useful in the production of biopharmaceuticals, where glycation can affect the quality and efficacy of the final product.

In the food industry, Recombinant Human FN3K can be used to develop new food products with reduced levels of AGEs. This can help in promoting healthier food options and reducing the risk of diseases associated with glycation.

Conclusion

Recombinant Human FN3K is a crucial protein that plays a significant role in regulating glucose metabolism and preventing the harmful effects of glycation. Its unique structure and enzymatic activity make it a potential therapeutic agent for the treatment of various diseases. Furthermore, its applications in biotechnology and food industry make it a valuable protein for the development of new products. Further research on Recombinant Human FN3K is needed to fully understand its potential and to explore its other possible applications.